Zdrowie i gospodarka · 03/08/2015

FDA Hosts Public Workshop on Surrogate Endpoints for Kidney Transplantation Clinical Trials

The FDA is hosting a public workshop to discuss surrogate endpoints for clinical trials in kidney transplantation, a process that aims to accelerate the development of new treatments for patients with end-stage renal disease. The workshop is part of the FDA's efforts to improve the efficiency and effectiveness of clinical trials in this area.